PDSB NASDAQ
PDS Biotechnology Corporation
1W: -6.1%
1M: +253.1%
3M: -11.5%
YTD: -10.2%
1Y: -26.6%
3Y: -85.3%
5Y: -95.5%
$0.75
+0.04 (+6.00%)
Weekly Expected Move ±48.3%
$0
$0
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (27)
PDS Biotechnology Corporation (NASDAQ:PDSB) Short Interest Update
Traders Buy Large Volume of Call Options on PDS Biotechnology (NASDAQ:PDSB)
PDS Biotech raises up to $22.55M in PIPE financing; shares surge premarket
HC Wainwright Analysts Increase Earnings Estimates for PDSB
PDS Biotech Reports Second Quarter 2026 Financial Results
Here's Why PDS Biotechnology (PDSB) Could be Great Choice for a Bottom Fisher
PDSB Q4 2025 Earnings Call Transcript
PDSB Q1 2026 Earnings Transcript
PDS Biotechnology Q1 2026 Earnings Call: Complete Transcript
Here are the major earnings before the open Wednesday
Why Is PDS Biotechnology Stock Gaining Wednesday?
What is HC Wainwright’s Estimate for PDSB FY2026 Earnings?
What is HC Wainwright’s Forecast for PDSB Q1 Earnings?
PDS Biotech outlines accelerated regulatory timeline after VERSATILE-003 protocol amendment
Earnings Scheduled For March 30, 2026
PDS Biotechnology GAAP EPS of -$0.74
PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement
PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement
Here are the major earnings before the open Monday
PDS Biotechnology FY 2025 Earnings Preview
Earnings week ahead: NKE, TLRY, SPCE, BYND, NNDM, CAG, and more
PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results
PDS Biotech Announces Conference Call and Webcast for 2025 Fourth Quarter and Year End Financial Results
PDS Biotechnology (NASDAQ:PDSB) Stock Price Up 9.1% – Time to Buy?
PDS Biotechnology (NASDAQ:PDSB) Shares Down 1.9% – Here’s What Happened
PDS Biotech Announces New Composition of Matter Patent for PDS0101 in Japan
PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why